Changes in E-cadherin in Endometrial Cancer
Author Information
Author(s): Miyamoto S, Baba H, Kuroda S, Kaibuchi K, Fukuda T, Maehara Y, Saito T
Primary Institution: National Kyushu Cancer Center
Hypothesis
E-cadherin function is thought to be impaired in epithelial cancer.
Conclusion
The study found that alterations in E-cadherin associated with cytoplasmic molecules differ between well and poorly differentiated endometrial adenocarcinomas.
Supporting Evidence
- E-cadherin and cytoplasmic molecules showed linear staining at cell boundaries in normal endometrium.
- In well differentiated adenocarcinomas, α-catenin and IQGAP1 disappeared from cell adhesive sites.
- In poorly differentiated adenocarcinomas, E-cadherin and cytoplasmic molecules formed large aggregates at cell adhesive sites.
- The expression of these molecules decreased or was lost in well differentiated adenocarcinomas compared to normal endometrium.
Takeaway
This study looked at how a protein called E-cadherin behaves in different types of endometrial cancer, finding that it acts differently in more and less aggressive forms of the disease.
Methodology
The study used immunofluorescence and immunoblotting techniques to examine E-cadherin and cytoplasmic molecules in endometrial cancer samples.
Participant Demographics
30 cases of endometrial adenocarcinomas, including 20 well differentiated and 10 poorly differentiated.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website